CNIB Annual Review[removed]

First Page		Document Content
Date: 2010-11-24 15:45:45 Health in Canada Ophthalmology Blindness Low vision Audiobook Visual impairment Vision loss Health Vision CNIB		CNIB Annual Review[removed] Add to Reading List Source URL: cnib.ca Download Document from Source Website File Size: 101,16 KB Share Document on Facebook

	2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES DocID: 1vr6Q - View Document
	PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno DocID: 1vlwz - View Document
	Postdoctoral Position in Computational Toxicology Co-hosted by CCAAM/CaCVAM, Health Canada, and Environment and Climate Change Canada We are seeking a highly motivated and experienced Postdoctoral Research Fellow to DocID: 1vlea - View Document
	Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w DocID: 1vkfE - View Document
	PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes    DocID: 1vjI2 - View Document